LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +82.1% | 1,185 | +117.8% | 0.00% | – |
| Q2 2023 | $39 | -92.0% | 544 | -92.5% | 0.00% | -100.0% |
| Q4 2022 | $485 | -99.9% | 7,269 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $625,000 | +691.1% | 7,269 | +720.4% | 0.00% | – |
| Q2 2022 | $79,000 | -20.2% | 886 | 0.0% | 0.00% | – |
| Q1 2022 | $99,000 | -25.6% | 886 | +2.2% | 0.00% | – |
| Q4 2021 | $133,000 | +19.8% | 867 | +8.1% | 0.00% | – |
| Q3 2021 | $111,000 | -2.6% | 802 | -8.2% | 0.00% | – |
| Q2 2021 | $114,000 | -13.0% | 874 | +1.2% | 0.00% | – |
| Q1 2021 | $131,000 | +54.1% | 864 | 0.0% | 0.00% | – |
| Q4 2020 | $85,000 | -84.3% | 864 | -84.1% | 0.00% | -100.0% |
| Q3 2019 | $542,000 | +110.1% | 5,449 | +140.9% | 0.00% | – |
| Q2 2019 | $258,000 | -42.5% | 2,262 | -36.7% | 0.00% | -100.0% |
| Q1 2019 | $449,000 | +218.4% | 3,576 | +243.5% | 0.00% | – |
| Q4 2018 | $141,000 | -83.7% | 1,041 | -94.4% | 0.00% | -100.0% |
| Q3 2014 | $867,000 | – | 18,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |